Study of ECC4703 With Sulfasalazine and Pitavastatin | MicrobiomeTrials← Back to trialsNCT07726368
Study of ECC4703 With Sulfasalazine and Pitavastatin
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-08-07Est. Completion: 2026-12
Enrollment target: 40 participants Locations- Nucleus Network Pty Ltd, Melbourne, Victoria, Australia
Other microbiome trials you might be interested in
Obesity, MorbidMetabolic SyndromeNASH - Nonalcoholic Steatohepatitis
Variable outcomes after weight loss surgery are likely attributable to complex, poorly understood mechanisms. Due to the…
Columbia, United StatesCompleted Mar 1, 2031
Diabetes Mellitus, Type 2Non-alcoholic Fatty Liver DiseaseObesityMetabolic Syndrome
VLCKD has showed to be an impactful diet on several metabolism aspects and has proven to be useful for preventing and tr…
Novara, ItalyEst. completion Jan 31, 2026